广州合和医药有限公司

Your current location: NEWS > Enterprise News

On June 9, 2025, potassium chloride injection (10ml: 1.5g) obtained the drug registration certificate and drug approval number (H20254263)
2025-06-09
On June 9, 2025, potassium chloride injection (10ml: 1.5g) obtained the drug registration certificate and drug approval number (H20254263)
On June 9, 2025, Sodium Bicarbonate Injection (10ml: 0.42g) obtained the drug registration certificate and drug approval number (H20254426)
2025-06-09
On June 9, 2025, Sodium Bicarbonate Injection (10ml: 0.42g) obtained the drug registration certificate and drug approval number (H20254426)
On May 13, 2025, Metoprolol Injection (10ml: 1g) obtained a drug registration certificate and drug approval number (H20254114)
2025-05-13
On May 13, 2025, Metoprolol Injection (10ml: 1g) obtained a drug registration certificate and drug approval number (H20254114)
On May 13, 2025, Calcium Chloride Injection (10ml: 1g) obtained the drug registration certificate and drug approval number (H20254084)
2025-05-13
On May 13, 2025, Calcium Chloride Injection (10ml: 1g) obtained the drug registration certificate and drug approval number (H20254084)

ABOUTUS

PRODUCTS

NEWS

R&D

JOIN US

Pharmacovigilance：400-8338-606

Add: Building 4, No. 3 Kexue Road, Huangpu District, Guangzhou City

Tel：020-31700995

Email：hr@nurinexpharma.com

Web：www.nurinexpharma.com